Clinical Trial Update: Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

This document reports an ongoing Phase II trial assessing the combination of palbociclib and ibrutinib in mantle cell lymphoma, with the study currently ACTIVE_…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Mantle Cell Lymphoma

Drugs mentioned

• Ibrutinib (ibrutinib)
• Palbociclib (palbociclib)

Snippet

Sponsor: Alliance Foundation Trials, LLC. | Conditions: Mantle Cell Lymphoma, B Cell Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING